Literature DB >> 29076125

Intracranial vasculopathy and infarct recurrence in children with sickle cell anaemia, silent cerebral infarcts and normal transcranial Doppler velocities.

Natasha A Choudhury1,2, Michael R DeBaun2, Maria R Ponisio3, Lori C Jordan4, Mark Rodeghier5, Sumit Pruthi6, Robert C McKinstry7.   

Abstract

Entities:  

Keywords:  children; intracranial vasculopathy; sickle cell anaemia; silent cerebral infarct; silent stroke

Mesh:

Year:  2017        PMID: 29076125      PMCID: PMC7133121          DOI: 10.1111/bjh.14979

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

Review 1.  Central nervous system complications and management in sickle cell disease.

Authors:  Michael R DeBaun; Fenella J Kirkham
Journal:  Blood       Date:  2016-01-12       Impact factor: 22.113

2.  Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.

Authors:  Michael R DeBaun; Mae Gordon; Robert C McKinstry; Michael J Noetzel; Desiree A White; Sharada A Sarnaik; Emily R Meier; Thomas H Howard; Suvankar Majumdar; Baba P D Inusa; Paul T Telfer; Melanie Kirby-Allen; Timothy L McCavit; Annie Kamdem; Gladstone Airewele; Gerald M Woods; Brian Berman; Julie A Panepinto; Beng R Fuh; Janet L Kwiatkowski; Allison A King; Jason M Fixler; Melissa M Rhodes; Alexis A Thompson; Mark E Heiny; Rupa C Redding-Lallinger; Fenella J Kirkham; Natalia Dixon; Corina E Gonzalez; Karen A Kalinyak; Charles T Quinn; John J Strouse; J Philip Miller; Harold Lehmann; Michael A Kraut; William S Ball; Deborah Hirtz; James F Casella
Journal:  N Engl J Med       Date:  2014-08-21       Impact factor: 91.245

3.  Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease.

Authors:  S T Miller; E A Macklin; C H Pegelow; T R Kinney; L A Sleeper; J A Bello; L D DeWitt; D M Gallagher; L Guarini; F G Moser; K Ohene-Frempong; N Sanchez; E P Vichinsky; W C Wang; D L Wethers; D P Younkin; R A Zimmerman; M R DeBaun
Journal:  J Pediatr       Date:  2001-09       Impact factor: 4.406

4.  Chronic and acute anemia and extracranial internal carotid stenosis are risk factors for silent cerebral infarcts in sickle cell anemia.

Authors:  Françoise Bernaudin; Suzanne Verlhac; Cécile Arnaud; Annie Kamdem; Manuela Vasile; Florence Kasbi; Isabelle Hau; Fouad Madhi; Christine Fourmaux; Sandra Biscardi; Ralph Epaud; Corinne Pondarré
Journal:  Blood       Date:  2014-12-22       Impact factor: 22.113

5.  Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease.

Authors:  Charles H Pegelow; Eric A Macklin; Franklin G Moser; Winfred C Wang; Jacqueline A Bello; Scott T Miller; Elliott P Vichinsky; Michael R DeBaun; Ludovico Guarini; Robert A Zimmerman; Donald P Younkin; Dianne M Gallagher; Thomas R Kinney
Journal:  Blood       Date:  2002-04-15       Impact factor: 22.113

6.  Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease.

Authors:  Monica L Hulbert; Robert C McKinstry; JoAnne L Lacey; Christopher J Moran; Julie A Panepinto; Alexis A Thompson; Sharada A Sarnaik; Gerald M Woods; James F Casella; Baba Inusa; Jo Howard; Fenella J Kirkham; Kofi A Anie; Jonathan E Mullin; Rebecca Ichord; Michael Noetzel; Yan Yan; Mark Rodeghier; Michael R Debaun
Journal:  Blood       Date:  2010-10-12       Impact factor: 22.113

Review 7.  Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia.

Authors:  Michael R DeBaun; F Daniel Armstrong; Robert C McKinstry; Russell E Ware; Elliot Vichinsky; Fenella J Kirkham
Journal:  Blood       Date:  2012-02-21       Impact factor: 22.113

8.  Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP study.

Authors:  Miguel R Abboud; Joel Cure; Suzanne Granger; Dianne Gallagher; Lewis Hsu; Winfred Wang; Gerald Woods; Brian Berman; Don Brambilla; Charles Pegelow; Jonathan Lewin; Robert A Zimmermann; Robert J Adams
Journal:  Blood       Date:  2003-12-18       Impact factor: 22.113

9.  Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography.

Authors:  R J Adams; V C McKie; L Hsu; B Files; E Vichinsky; C Pegelow; M Abboud; D Gallagher; A Kutlar; F T Nichols; D R Bonds; D Brambilla
Journal:  N Engl J Med       Date:  1998-07-02       Impact factor: 91.245

10.  Magnetic resonance angiography-defined intracranial vasculopathy is associated with silent cerebral infarcts and glucose-6-phosphate dehydrogenase mutation in children with sickle cell anaemia.

Authors:  Mathula Thangarajh; Genyan Yang; Dana Fuchs; Maria R Ponisio; Robert C McKinstry; Alok Jaju; Michael J Noetzel; James F Casella; Emily Barron-Casella; W Craig Hooper; Sheree L Boulet; Christopher J Bean; Meredith E Pyle; Amanda B Payne; Jennifer Driggers; Heidi A Trau; Bruce A Vendt; Mark Rodeghier; Michael R DeBaun
Journal:  Br J Haematol       Date:  2012-09-07       Impact factor: 6.998

  10 in total
  11 in total

1.  Impaired Collateral Vessel Formation in Sickle Cell Disease.

Authors:  Derick Okwan-Duodu; Laura Hansen; Giji Joseph; Alicia N Lyle; Daiana Weiss; David R Archer; W Robert Taylor
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-03-15       Impact factor: 8.311

2.  Choroid plexus perfusion in sickle cell disease and moyamoya vasculopathy: Implications for glymphatic flow.

Authors:  Skylar E Johnson; Colin D McKnight; Lori C Jordan; Daniel O Claassen; Spencer Waddle; Chelsea Lee; Maria Garza; Niral J Patel; L Taylor Davis; Sumit Pruthi; Paula Trujillo; Rohan Chitale; Matthew Fusco; Manus J Donahue
Journal:  J Cereb Blood Flow Metab       Date:  2021-04-28       Impact factor: 6.200

3.  Silent infarcts in sickle cell disease occur in the border zone region and are associated with low cerebral blood flow.

Authors:  Andria L Ford; Dustin K Ragan; Slim Fellah; Michael M Binkley; Melanie E Fields; Kristin P Guilliams; Hongyu An; Lori C Jordan; Robert C McKinstry; Jin-Moo Lee; Michael R DeBaun
Journal:  Blood       Date:  2018-07-30       Impact factor: 25.476

4.  Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.

Authors:  Lise J Estcourt; Ruchika Kohli; Sally Hopewell; Marialena Trivella; Winfred C Wang
Journal:  Cochrane Database Syst Rev       Date:  2020-07-27

5.  Interventions for preventing silent cerebral infarcts in people with sickle cell disease.

Authors:  Lise J Estcourt; Catherine Kimber; Sally Hopewell; Marialena Trivella; Carolyn Doree; Miguel R Abboud
Journal:  Cochrane Database Syst Rev       Date:  2020-04-06

Review 6.  Targeting sickle cell disease root-cause pathophysiology with small molecules.

Authors:  Yogen Saunthararajah
Journal:  Haematologica       Date:  2019-08-08       Impact factor: 9.941

7.  Vascular Instability and Neurological Morbidity in Sickle Cell Disease: An Integrative Framework.

Authors:  Hanne Stotesbury; Jamie M Kawadler; Patrick W Hales; Dawn E Saunders; Christopher A Clark; Fenella J Kirkham
Journal:  Front Neurol       Date:  2019-08-13       Impact factor: 4.003

8.  Intracranial and Extracranial Vascular Stenosis as Risk Factors for Stroke in Sickle Cell Disease.

Authors:  Alyssa A Schlotman; Manus J Donahue; Adetola A Kassim; Chelsea A Lee; Spencer L Waddle; Sumit Pruthi; L Taylor Davis; Mark Rodeghier; Michael R DeBaun; Lori C Jordan
Journal:  Pediatr Neurol       Date:  2020-10-22       Impact factor: 3.372

9.  Safety of 3 Tesla Magnetic Resonance Imaging in Patients with Sickle Cell Disease.

Authors:  Olivia Justice; Lori C Jordan; Chelsea A Lee; Niral J Patel; Spencer Waddle; Sumit Pruthi; L Taylor Davis; Adetola A Kassim; Manus J Donahue
Journal:  Radiol Res Pract       Date:  2021-05-11

10.  MRI detection of brain abnormality in sickle cell disease.

Authors:  Hanne Stotesbury; Jamie Michelle Kawadler; Dawn Elizabeth Saunders; Fenella Jane Kirkham
Journal:  Expert Rev Hematol       Date:  2021-06-07       Impact factor: 2.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.